Allergy Immunotherapies Market To Reach US$ 5.0 Billion by 2028 | CAGR of 9.8%

IMARC Group's latest research report, titled "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," the global allergy immunotherapies market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.

Allergy Immunotherapies Market Growth and Development:

The inflating pollution levels and the rising number of active and passive smokers are primarily driving the allergy immunotherapy market. Additionally, the growing healthcare expenditure capacities of individuals, the escalating demand for long-term treatment options, and the increasing prevalence of allergies, on account of several lifestyle changes and environmental factors, are further catalyzing the market growth. Besides this, the launch of favorable policies by government bodies to spread awareness regarding the high efficacy rates of the therapy is acting as another significant growth-inducing factor. Moreover, continuous advancements in drug development technologies and the widespread adoption of allergy immunotherapy to alter the course of the allergy with persistent effects are positively influencing the global market. Apart from this, the development of targeted drugs for allergies in the form of sublingual immunotherapy (SLIT) tablets and allergen immunotherapy tablets (AITs) is also stimulating the market growth. Furthermore, extensive investments in R&D activities are anticipated to fuel the allergy immunotherapy market over the forecasted period.

Get Sample Copy of Report at - https://www.imarcgroup.com/allergy-immunotherapies-market/requestsample

Key Players Included in Global Allergy Immunotherapies Market Research Report:

• ALK-Abello A/S
• Allergy Therapeutics
• Stallergenes Greer
• HAL Allergy Group
• DBV Technologies
• Merck Group
• Aimmune Therapeutics
• Circassia Pharmaceuticals
• Anergis SA
• Biomay AG

Allergy Immunotherapies Trends:

Allergy immunotherapy, also called desensitization or hypo-sensitization, represents a long-term medical treatment that usually aims to desensitize the immune system of an individual against specific allergens that trigger allergy symptoms. It alters the response of the immune system by gradually increasing the doses of the allergen. In addition to this, allergy immunotherapy assists in offering long-term impact, elevating immunological tolerance, reducing inflammation, changing the course of the disease, improving the quality of life, etc. Consequently, it is extensively utilized for treating allergic rhinitis, peanuts allergy, allergic asthma, cat allergy, conjunctivitis, and other kinds of hypersensitivity.

Browse Full Report With TOC: https://www.imarcgroup.com/allergy-immunotherapies-market

Key Market Segmentation:

Breakup by Treatment Type:

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others

Breakup by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

TOC for the Allergy Immunotherapies Market Research Report:

• Preface
• Scope and Methodology
• Executive Summary
• Introduction
• Global Allergy Immunotherapies Market
• SWOT Analysis
• Value Chain Analysis
• Price Analysis
• Competitive Landscape

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.